For the year ending 2025-12-31, LENZ has $305,876K in assets. $21,537K in debts. $25,179K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 25,179 | |||
| Marketable securities | 267,168 | |||
| Accounts receivable, net | 329 | |||
| Inventory | 2,936 | |||
| Prepaid expenses and other current assets | 5,800 | |||
| Restricted cash | 0 | |||
| Total current assets | 301,412 | |||
| Property and equipment, net | 1,189 | |||
| Operating lease right-of-use asset | 734 | |||
| Other assets | 2,541 | |||
| Total assets | 305,876 | |||
| Accounts payable | 4,167 | |||
| Accrued liabilities | 17,020 | |||
| Total current liabilities | 21,187 | |||
| Operating lease liability, net | 350 | |||
| Total liabilities | 21,537 | |||
| Common stock, par value of 0.00001 per share 300,000,000 shares authorized at december31, 2025 and 2024 31,344,782 and 27,531,490 shares issued at december31, 2025 and 2024, respectively and 31,344,782 and 27,518,439 shares outstanding at december31, 2025 and 2024, respectively | 1 | |||
| Additional paid-in capital | 511,237 | |||
| Accumulated deficit | -227,141 | |||
| Accumulated other comprehensive income | 242 | |||
| Total stockholders equity | 284,339 | |||
| Total liabilities and stockholders equity | 305,876 | |||
LENZ Therapeutics, Inc. (LENZ)
LENZ Therapeutics, Inc. (LENZ)